BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF 24.80
-0.40 (-1.59%)
At close: Aug 21, 2026
BioVersys AG Market Cap
BioVersys AG has a market cap or net worth of 145.46 million as of August 21, 2026. Its market cap has decreased by -3.19% in one year.
Market Cap
145.46M
Enterprise Value
84.68M
Revenue
3.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.80
ChartMarket Cap Chart
Since February 6, 2025, BioVersys AG's market cap has decreased from 207.92M to 145.46M, a decrease of -30.04%. That is a compound annual growth rate of -20.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 145.46M | 1.94% |
| Dec 30, 2025 | 142.69M | -31.37% |
| Feb 6, 2025 | 207.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.74B |
| Idorsia | 1.52B |
| Basilea Pharmaceutica AG | 775.19M |
| Newron Pharmaceuticals | 269.64M |
| Santhera Pharmaceuticals Holding AG | 258.63M |
| Molecular Partners AG | 130.54M |
| Xlife Sciences AG | 87.53M |
| MindMaze Therapeutics Holding | 31.82M |